Develogen

Antag Therapeutics

This company develops GIP receptor antagonist therapies to treat patients living with obesity, type 2 diabetes and metabolic disorders.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

Fable Therapeutics

The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

Alveus Therapeutics

This clinical-stage biotechnology company develops next-generation therapies for obesity and metabolic diseases to provide sustained weight loss for patients.

Kailera

This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.